amfAR, The Foundation for AIDS Research

Pediatric HIV Program

 peds section.JPG
Photo: Kevin Tachman

TREAT Asia’s Pediatric HIV Program supports projects that focus on expanding access to treatment and improving the quality of care that children and adolescents receive. It is the only regional program that integrates research to optimize pediatric HIV care and treatment with trainings to improve the pediatric HIV knowledge of caregivers, community advocates, and healthcare providers. The program also seeks to support HIV-positive adolescents’ unique developmental needs.

The pediatric program’s Social Support Awards help organizations train care providers on how to best address the psychosocial needs of children and adolescents. Additionally, TREAT Asia is participating in the International AIDS Society’s (IAS) Collaborative Initiative for Paediatric HIV Education and Research (CIPHER), which aims to facilitate global collaboration to improve care for HIV-positive children and adolescents.

Featured Articles

AIDS LIFE and TREAT Asia Team Up to Fight Pediatric HIV in Asia

Study Shows HIV-Positive Adolescents in Asia Are at Increased Risk of High-Risk HPV

TREAT Asia’s New Program to Help Build Regional Youth HIV Advocacy Capacity

Community Profile: Worldwide Orphans Foundation Vietnam

amfAR’s Pediatric Cure Think Tank Features Thai Study

Improving Reproductive Health Among HIV-Positive Adolescents

Training Community Leaders to Improve HIV Support for Children

Supporting the Psychosocial Needs of HIV-Positive Children and Adolescents
Mastering the Art of Pediatric HIV Treatment

TREAT Asia Pediatric Researcher Receives an IAS CIPHER Grant

TREAT Asia Study on ARV Resistance in Children Reaches Its Goal

New Global Pediatric HIV Database to Investigate Critical Research Gaps
Earlier Is Better: Antiretroviral Therapy Initiation in Asian Perinatally HIV-infected Adolescents

Children Continue to Start HIV Treatment too Late

HPV–Another Challenge for Adolescent Girls Growing Up with HIV

Lopinavir/Ritonavir Should Not Be Used Alone as Second-Line Therapy in Adults

Mastering the Art of Pediatric HIV Treatment